Published in J Virol on February 26, 2014
Defective viral genomes: critical danger signals of viral infections. J Virol (2014) 0.89
Influenza virus activation of the interferon system. Virus Res (2015) 0.88
Influenza Virus Reassortment Is Enhanced by Semi-infectious Particles but Can Be Suppressed by Defective Interfering Particles. PLoS Pathog (2015) 0.84
Cloned Defective Interfering Influenza RNA and a Possible Pan-Specific Treatment of Respiratory Virus Diseases. Viruses (2015) 0.83
High-Throughput Single-Cell Kinetics of Virus Infections in the Presence of Defective Interfering Particles. J Virol (2015) 0.80
Low-Fidelity Polymerases of Alphaviruses Recombine at Higher Rates To Overproduce Defective Interfering Particles. J Virol (2015) 0.78
Distinct effects of T-705 (favipiravir) and ribavirin on influenza virus replication and viral RNA synthesis. Antimicrob Agents Chemother (2016) 0.77
Exploiting Genetic Interference for Antiviral Therapy. PLoS Genet (2016) 0.76
A Defective Interfering Influenza RNA Inhibits Infectious Influenza Virus Replication in Human Respiratory Tract Cells: A Potential New Human Antiviral. Viruses (2016) 0.75
The evolutionary ecology of molecular replicators. R Soc Open Sci (2016) 0.75
(In)validating experimentally derived knowledge about influenza A defective interfering particles. J R Soc Interface (2016) 0.75
Non-encapsidated 5' copy-back defective-interfering genomes produced by recombinant measles viruses are recognized by RIG-I and LGP2 but not MDA5. J Virol (2017) 0.75
Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses. Viruses (2017) 0.75
Origins and Mechanisms of miRNAs and siRNAs. Cell (2009) 20.77
Propagation of the PR8 strain of influenza A virus in chick embryos. II. The formation of incomplete virus following inoculation of large doses of seed virus. Acta Pathol Microbiol Scand (1951) 5.59
Defective interfering viruses. Annu Rev Microbiol (1973) 4.21
Anatomy of herpes simplex virus DNA. III. Characterization of defective DNA molecules and biological properties of virus populations containing them. J Virol (1975) 4.19
Incomplete forms of influenza virus. Adv Virus Res (1954) 3.05
Defective virions of herpes simplex viruses. Intervirology (1973) 3.03
Molecular cloning of natural paramyxovirus copy-back defective interfering RNAs and their expression from DNA. Virology (1992) 2.89
Does the higher order structure of the influenza virus ribonucleoprotein guide sequence rearrangements in influenza viral RNA? Cell (1983) 2.42
Genome packaging in influenza A virus. J Gen Virol (2009) 2.40
Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog (2008) 2.38
Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol (2010) 2.28
Sendai virus defective-interfering genomes and the activation of interferon-beta. Virology (2006) 2.28
Prophylaxis and immunization in mice by use of virus-free defective T particles to protect against intracerebral infection by vesicular stomatitis virus. Proc Natl Acad Sci U S A (1973) 2.05
Induction and biological properties of defective interfering particles of rabies virus. J Virol (1977) 2.02
Study of infectivity and hemagglutination of influenza virus in deembryonated eggs. J Immunol (1950) 1.85
Defective interfering viruses and infections of animals. Curr Top Microbiol Immunol (1986) 1.83
Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets. PLoS Pathog (2010) 1.81
Classical swine fever virus: recovery of infectious viruses from cDNA constructs and generation of recombinant cytopathogenic defective interfering particles. J Virol (1996) 1.74
Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses. Lancet (1975) 1.74
Factors involved in the generation and replication of rhabdovirus defective T particles. J Virol (1976) 1.72
On the reproduction of influenza virus; quantitative studies with procedures which enumerate infective and hemagglutinating virus particles. J Exp Med (1954) 1.68
MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai Virus defective interfering particles. J Immunol (2008) 1.68
Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J Virol (2010) 1.66
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis (2011) 1.66
The generation and propagation of defective-interfering particles of Semliki Forest virus in different cell types. Virology (1978) 1.62
Purification of defective interfering T particles of vesicular stomatitis and rabies viruses generated in vivo in brains of newborn mice. Virology (1975) 1.54
Complete sequence analyses show that two defective interfering influenza viral RNAs contain a single internal deletion of a polymerase gene. Proc Natl Acad Sci U S A (1982) 1.52
A novel role for viral-defective interfering particles in enhancing dendritic cell maturation. J Immunol (2006) 1.51
The fitness of defective interfering murine coronavirus DI-a and its derivatives is decreased by nonsense and frameshift mutations. J Virol (1992) 1.49
Defective interfering particles with covalently linked [+/-]RNA induce interferon. Nature (1977) 1.44
Sequence relationships among defective interfering influenza viral RNAs. Proc Natl Acad Sci U S A (1979) 1.41
Propagation of the PR8 strain of influenza A virus in chick embryos. III. Properties of the incomplete virus produced in serial passages of undiluted virus. Acta Pathol Microbiol Scand (1951) 1.40
Influenza defective interfering viral RNA is formed by internal deletion of genomic RNA. Proc Natl Acad Sci U S A (1980) 1.39
Reproduction of influenza viruses; quantitative investigations with particle enumeration procedures on the dynamics of influenza A and B virus reproduction. J Exp Med (1955) 1.37
On the genesis of incomplete Sendai virions. Virology (1970) 1.35
Infectivity and nucleic acid content of influenza virus. Nature (1955) 1.34
Origin of small RNA in von Magnus particles of influenza virus. J Virol (1979) 1.33
Defective interfering viral particles in acute dengue infections. PLoS One (2011) 1.25
Viral RNAs: lessons from the enemy. Cell (2009) 1.25
Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia. Vaccine (2003) 1.23
Biological modification of rabies virus as a result of its adaptation to chicks and developing chick embryos. Bull World Health Organ (1954) 1.21
Attempts to detect homologous autointerference in vivo with influenza virus and vesicular stomatitis virus. Infect Immun (1973) 1.21
Equine herpesvirus in vivo: cyclic production of a DNA density variant with repetitive sequences. Virology (1976) 1.16
Structure of influenza virus ribonucleoprotein complexes and their packaging into virions. Rev Med Virol (2010) 1.14
Deep sequencing analysis of defective genomes of parainfluenza virus 5 and their role in interferon induction. J Virol (2013) 1.12
Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virus. J Virol (2013) 1.12
Generation of defective virus after infection of newborn rats with reovirus. J Virol (1976) 1.11
Prevention of death in Semliki Forest virus-infected mice by administration of defective-interfering Semliki Forest virus. J Gen Virol (1978) 1.09
The RNAs of defective-interfering influenza virus. Virology (1978) 1.09
Molecular cloning of a defective hepatitis C virus genome from the ascitic fluid of a patient with hepatocellular carcinoma. J Gen Virol (1997) 1.08
A defective interference-like phenomenon of human hepatitis B virus in chronic carriers. J Virol (1998) 1.07
Defective segment 1 RNAs that interfere with production of infectious influenza A virus require at least 150 nucleotides of 5' sequence: evidence from a plasmid-driven system. J Gen Virol (2002) 1.06
Artificial production of incomplete influenza virus. Nature (1954) 1.06
Host function-dependent induction of defective interfering particles of vesicular stomatitis virus. J Virol (1978) 1.06
Viruses isolated from cells persistently infected with vesicular stomatitis virus show altered interactions with defective interfering particles. J Virol (1980) 1.05
Defective interfering virus particles modulate virulence. J Virol (1985) 1.04
Approximately 150 nucleotides from the 5' end of an influenza A segment 1 defective virion RNA are needed for genome stability during passage of defective virus in infected cells. Virology (2000) 1.03
Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. J Virol (2008) 1.02
A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo. Vaccine (2011) 1.01
Interferon induction by viruses. VIII. Vesicular stomatitis virus: [+/-]DI-011 particles induce interferon in the absence of standard virions. Virology (1982) 0.99
Sequence of DNA complementary to a small RNA segment of influenza virus A/NT/60/68. Nucleic Acids Res (1981) 0.99
Propagation of the PR8 strain of influenza A virus in chick embryos. IV. Studies on the factors involved in the formation of incomplete virus upon serial passage of undiluted virus. Acta Pathol Microbiol Scand (1952) 0.99
Interferon induction by viruses. XIX. Vesicular stomatitis virus--New Jersey: high multiplicity passages generate interferon-inducing, defective-interfering particles. Virology (1989) 0.97
Phylodynamic analysis of the emergence and epidemiological impact of transmissible defective dengue viruses. PLoS Pathog (2013) 0.97
Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing. Vaccine (2004) 0.95
Requirements for DI particle prophylaxis against vesicular stomatitis virus infection in vivo. J Gen Virol (1980) 0.95
Protection of mice from lethal influenza by adoptive transfer of non-neutralizing haemagglutination-inhibiting IgG obtained from the lungs of infected animals treated with defective interfering virus. J Gen Virol (1989) 0.95
Transneuronal spread of Semliki Forest virus in the developing mouse olfactory system is determined by neuronal maturity. Neuroscience (1998) 0.95
Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection. Vaccine (2006) 0.94
Common sequence elements in structurally unrelated genomes of defective interfering Semliki Forest virus. Virology (1994) 0.93
Detection of defective genomes in hepatitis A virus particles present in clinical specimens. J Gen Virol (1989) 0.93
Formation of non-infectious influenza virus in mouse lungs: its dependence upon extensive pulmonary consolidation initiated by the viral inoculum. J Exp Med (1954) 0.93
The production of incomplete virus particles among influenza strains: experiments in eggs. Br J Exp Pathol (1954) 0.91
Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir. Antiviral Res (2012) 0.91
Defective interfering influenza A virus protects in vivo against disease caused by a heterologous influenza B virus. J Gen Virol (2011) 0.91
Protection of mice from lethal influenza: evidence that defective interfering virus modulates the immune response and not virus multiplication. J Gen Virol (1986) 0.91
Detection of vesicular stomatitis virus RNA and its defective-interfering particles in individual mouse brains. J Virol (1984) 0.91
The influence of defective-interfering particles of the PR-8 strain of influenza A virus on the pathogenesis of pulmonary infection in mice. J Infect Dis (1979) 0.91
Prevention of virus-induced cerebellar diseases by defective-interfering lymphocytic choriomeningitis virus. J Infect Dis (1977) 0.90
Detection of truncated virus particles in a persistent RNA virus infection in vivo. J Virol (1995) 0.90
Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles. PLoS One (2013) 0.89
Altered replicase specificity is responsible for resistance to defective interfering particle interference of an Sdi- mutant of vesicular stomatitis virus. J Virol (1988) 0.87
Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza A virus and allows protective immunity to be established. PLoS One (2012) 0.86
Generation of defective interfering particles by two vaccine strains of measles virus. Virology (1996) 0.86
Mediators of protection against lethal systemic vesicular stomatitis virus infection in hamsters: defective interfering particles, polyinosinate-polycytidylate, and interferon. Infect Immun (1982) 0.85
A versatile RNA vector for delivery of coding and noncoding RNAs. J Virol (2013) 0.85
The receptor preference of influenza viruses. Influenza Other Respir Viruses (2010) 0.85
Ocular tropism of respiratory viruses. Microbiol Mol Biol Rev (2013) 0.84
Defective interfering type A equine influenza virus (H3N8) protects mice from morbidity and mortality caused by homologous and heterologous subtypes of influenza A virus. J Gen Virol (1994) 0.83
Protection of three strains of mice against lethal influenza in vivo by defective interfering virus. Virus Res (1993) 0.83
Defective interfering virus protects elderly mice from influenza. Virol J (2011) 0.83
Suppression of vesicular stomatitis virus defective intefering particle generation by a function(s) associated with human chromosome 16. J Virol (1981) 0.83
Intracellular stability of the interfering activity of a defective interfering influenza virus in the absence of virus multiplication. Virology (1987) 0.83
Defective interfering influenza virus inhibits immunopathological effects of infectious virus in the mouse. J Virol (1992) 0.82
Quantitative studies on influenza virus infection of the chick embryo by the amniotic route. J Bacteriol (1956) 0.82
The genomic sequence of defective interfering Semliki Forest virus (SFV) determines its ability to be replicated in mouse brain and to protect against a lethal SFV infection in vivo. Virology (1998) 0.81
Defective influenza A virus generated entirely from plasmids: its RNA is expressed in infected mouse lung and modulates disease. J Virol Methods (2003) 0.81
Retrograde transport pathways utilised by viruses and protein toxins. Virol J (2006) 1.61
Inflammatory responses to pneumovirus infection in IFN-alpha beta R gene-deleted mice. J Immunol (2005) 1.34
Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo. J Virol (2004) 1.28
Activation and inactivation of antiviral CD8 T cell responses during murine pneumovirus infection. J Immunol (2005) 1.18
The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention. Pharmacol Ther (2005) 1.16
Differential expression of proinflammatory cytokine genes in vivo in response to pathogenic and nonpathogenic pneumovirus infections. J Infect Dis (2002) 1.13
Coupled translation of the respiratory syncytial virus M2 open reading frames requires upstream sequences. J Biol Chem (2005) 1.12
Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents. J Virol (2003) 1.08
Translation toeprinting assays using fluorescently labeled primers and capillary electrophoresis. Biotechniques (2005) 0.99
Ciliary dyskinesia is an early feature of respiratory syncytial virus infection. Eur Respir J (2013) 0.94
Development of a reverse-genetics system for Avian pneumovirus demonstrates that the small hydrophobic (SH) and attachment (G) genes are not essential for virus viability. J Gen Virol (2004) 0.93
Respiratory syncytial virus increases the virulence of Streptococcus pneumoniae by binding to penicillin binding protein 1a. A new paradigm in respiratory infection. Am J Respir Crit Care Med (2014) 0.92
Defective interfering influenza A virus protects in vivo against disease caused by a heterologous influenza B virus. J Gen Virol (2011) 0.91
Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir. Antiviral Res (2012) 0.91
Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir. PLoS One (2014) 0.88
Rabies virus vaccines: is there a need for a pan-lyssavirus vaccine? Vaccine (2012) 0.88
Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza A virus and allows protective immunity to be established. PLoS One (2012) 0.86
Deletion of the SH gene from avian metapneumovirus has a greater impact on virus production and immunogenicity in turkeys than deletion of the G gene or M2-2 open reading frame. J Gen Virol (2008) 0.85
Diminished expression of an antiviral ribonuclease in response to pneumovirus infection in vivo. Antiviral Res (2003) 0.83
Defective interfering virus protects elderly mice from influenza. Virol J (2011) 0.83
Pre-existing virus-specific CD8(+) T-cells provide protection against pneumovirus-induced disease in mice. Vaccine (2012) 0.82
Roles of the PVM M2-1, M2-2 and P gene ORF 2 (P-2) proteins in viral replication. Virus Res (2007) 0.81
Cellular mRNAs access second ORFs using a novel amino acid sequence-dependent coupled translation termination-reinitiation mechanism. RNA (2014) 0.80
Mutational analysis of the gene start sequences of pneumonia virus of mice. Virus Res (2007) 0.80
Pulmonary eosinophilia in mice devoid of interleukin-5. J Leukoc Biol (2002) 0.79
Avian metapneumovirus SH gene end and G protein mutations influence the level of protection of live-vaccine candidates. J Gen Virol (2007) 0.78
Comparative modeling of CCRL1, a key protein in masked immune diseases and virtual screening for finding inhibitor of this protein. Bioinformation (2012) 0.77
Mutational analysis of the avian pneumovirus conserved transcriptional gene start sequence identifying critical residues. J Gen Virol (2005) 0.75
The host-range tdCE phenotype of Chandipura virus is determined by mutations in the polymerase gene. J Gen Virol (2013) 0.75
Stimulation of pneumovirus-specific CD8+ T-cells using a non-toxic recombinant ricin delivery system. Mol Immunol (2006) 0.75